The JI
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     
 


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Yu, W.
Right arrow Articles by Vercelli, D.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Yu, W.
Right arrow Articles by Vercelli, D.
Right arrowPubmed/NCBI databases
*Substance via MeSH
The Journal of Immunology, 1998, 161: 4244-4251.
Copyright © 1998 by The American Association of Immunologists

Soluble CD141–152 Confers Responsiveness to Both Lipoarabinomannan and Lipopolysaccharide in a Novel HL-60 Cell Bioassay1

Weiming Yu2,*, Elisa Soprana2,*, Giovanna Cosentino*, Manuela Volta*, Henri S. Lichenstein{ddagger}, Giovanna Viale*,{dagger} and Donata Vercelli3,*

* Molecular Immunoregulation Unit, San Raffaele Scientific Institute, and {dagger} Department of Biology and Genetics, University of Milan, Milan, Italy; and {ddagger} Amgen, Inc., Boulder, CO 80301

CD14 is a pattern recognition receptor involved in the interaction with multiple ligands, including LPS from Gram-negative bacteria and lipoarabinomannan (LAM) from mycobacteria. While the interactions between LPS and soluble CD14 (sCD14) have been analyzed in detail, LAM/CD14 interactions remain uncharacterized due to the lack of suitable functional assays. We describe herein a novel bioassay for the analysis of CD14/ligand interactions. CD14-negative myeloid HL-60 cells up-regulate endogenous CD14 gene expression when stimulated with LPS in the presence of recombinant soluble CD141–348. Using the HL-60 bioassay, we showed that sCD141–348 confers responsiveness not only to LPS, but also to LAM. The response to LAM, but not that to LPS, was highly dependent on LPS binding protein (LBP). The N-terminal half of CD14 was sufficient to mediate HL-60 responses to LAM, since HL-60 cells responded with similar efficiency when stimulated with LAM and LBP in the presence of sCD141–348 or sCD141–152. Thus, the N-terminal 152 amino acids of CD14 contain the site(s) involved in the interaction with LAM and LBP, as well as the residues required for LAM-dependent CD14 signaling.




This article has been cited by other articles:


Home page
CVIHome page
M. Mizusawa, M. Kawamura, M. Takamori, T. Kashiyama, A. Fujita, M. Usuzawa, H. Saitoh, Y. Ashino, I. Yano, and T. Hattori
Increased Synthesis of Anti-Tuberculous Glycolipid Immunoglobulin G (IgG) and IgA with Cavity Formation in Patients with Pulmonary Tuberculosis
Clin. Vaccine Immunol., March 1, 2008; 15(3): 544 - 548.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
P. Prohinar, F. Re, R. Widstrom, D. Zhang, A. Teghanemt, J. P. Weiss, and T. L. Gioannini
Specific High Affinity Interactions of Monomeric Endotoxin{middle dot}Protein Complexes with Toll-like Receptor 4 Ectodomain
J. Biol. Chem., January 12, 2007; 282(2): 1010 - 1017.
[Abstract] [Full Text] [PDF]


Home page
Infect. Immun.Home page
E. Elass, L. Aubry, M. Masson, A. Denys, Y. Guerardel, E. Maes, D. Legrand, J. Mazurier, and L. Kremer
Mycobacterial Lipomannan Induces Matrix Metalloproteinase-9 Expression in Human Macrophagic Cells through a Toll-Like Receptor 1 (TLR1)/TLR2- and CD14-Dependent Mechanism
Infect. Immun., October 1, 2005; 73(10): 7064 - 7068.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Respir. Crit. Care Med.Home page
C. W. Wieland, S. Knapp, S. Florquin, A. F. de Vos, K. Takeda, S. Akira, D. T. Golenbock, A. Verbon, and T. van der Poll
Non-Mannose-capped Lipoarabinomannan Induces Lung Inflammation via Toll-like Receptor 2
Am. J. Respir. Crit. Care Med., December 15, 2004; 170(12): 1367 - 1374.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
C. Vignal, Y. Guerardel, L. Kremer, M. Masson, D. Legrand, J. Mazurier, and E. Elass
Lipomannans, But Not Lipoarabinomannans, Purified from Mycobacterium chelonae and Mycobacterium kansasii Induce TNF-{alpha} and IL-8 Secretion by a CD14-Toll-Like Receptor 2-Dependent Mechanism
J. Immunol., August 15, 2003; 171(4): 2014 - 2023.
[Abstract] [Full Text] [PDF]


Home page
Clin. Microbiol. Rev.Home page
E. S. Van Amersfoort, T. J. C. Van Berkel, and J. Kuiper
Receptors, Mediators, and Mechanisms Involved in Bacterial Sepsis and Septic Shock
Clin. Microbiol. Rev., July 1, 2003; 16(3): 379 - 414.
[Abstract] [Full Text] [PDF]


Home page
Infect. Immun.Home page
L. A. Augusto, M. Synguelakis, J. Johansson, T. Pedron, R. Girard, and R. Chaby
Interaction of Pulmonary Surfactant Protein C with CD14 and Lipopolysaccharide
Infect. Immun., January 1, 2003; 71(1): 61 - 67.
[Abstract] [Full Text] [PDF]


Home page
Clin. Microbiol. Rev.Home page
R. van Crevel, T. H. M. Ottenhoff, and J. W. M. van der Meer
Innate Immunity to Mycobacterium tuberculosis
Clin. Microbiol. Rev., April 1, 2002; 15(2): 294 - 309.
[Abstract] [Full Text] [PDF]


Home page
Innate ImmunityHome page
S. L. Orr and P. Tobias
LPS and LAM activation of the U373 astrocytoma cell line: Differential requirement for CD14
Innate Immunity, June 1, 2000; 6(3): 215 - 222.
[Abstract] [PDF]


Home page
J. Virol.Home page
S. D. Lawn, B. D. Roberts, G. E. Griffin, T. M. Folks, and S. T. Butera
Cellular Compartments of Human Immunodeficiency Virus Type 1 Replication In Vivo: Determination by Presence of Virion-Associated Host Proteins and Impact of Opportunistic Infection
J. Virol., January 1, 2000; 74(1): 139 - 145.
[Abstract] [Full Text]


Home page
Proc. Natl. Acad. Sci. USAHome page
D. M. Underhill, A. Ozinsky, K. D. Smith, and A. Aderem
Toll-like receptor-2 mediates mycobacteria-induced proinflammatory signaling in macrophages
PNAS, December 7, 1999; 96(25): 14459 - 14463.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
This Website Copyright © 1998 by The American Association of Immunologists, Inc. All rights reserved.
All Contents Copyright © 1998 by The American Association of Immunologists, Inc. All rights reserved.